首页> 外国专利> COMPOSITIONS OF SEQUENTIAL SYNTHETIC CULTURE MEDIA FOR IN VITRO HUMAN EMBRYONIC DEVELOPMENT AND METHODS USING THEREOF

COMPOSITIONS OF SEQUENTIAL SYNTHETIC CULTURE MEDIA FOR IN VITRO HUMAN EMBRYONIC DEVELOPMENT AND METHODS USING THEREOF

机译:体外人胚胎发育的序贯合成培养基的组成及其使用方法

摘要

A sequential synthetic culture media composition for in vitro embryo development is provided to supply more physiological nutrition to embryo growing at each stage of early embryo, morula, and late embryo and be able to maintain high pregnancy rate and implantation rate when the embryo is transplanted on the womb. The composition consists of a synthetic culture buffer solution(SCB) and a synthetic adding solution for early embryo growth(SAG13) in a volumetric ratio of 85:15. The SCB is prepared by dissolving 91.53mM of NaCl, 5mM of KCl, 0.8mM of MgSO4À7H2O, 1.80mM of CaCl2À2H2O, 0.17mM of Na2HPO4, 0.08mM of KH2PO4, 5mM of KHCO3, 20mM of NaHCO3, 0.1 mM of sodium pyruvate, 11.74mM of D,L-sodium lactate, 0.58mM of D-glucose, 15ml of SNEasS(x66.67), 15ml of SEaaS(x66.67), 0.611mM of L-alanyl-L-glutamine, 0.3594mM of glycyl-L-glutamineÀH2O, 0.003mM of D-Ca-pantothenate, 0.000716mM of choline chloride, 0.00027mM of folic acid, 0.0011mM of i-inositol, 0.000819mM of nicotinamide, 0.000491mM of pyridoxal HCl, 0.0000266mM of riboflavin, 0.000296mM of thiamine HCl, 0.1052mM of penicillin-G, 0.0172mM of streptomycin-S, and 0.003mM of phenol red in 1 liter of ultra-pure water. The SAG13 is prepared by dissolving 14.44mM of NaCl, 5mM of KCl, 3.5mM of MgSO4À7H2O, 1.80mM of CaCl2À2H2O, 0.17mM of Na2HPO4, 0.08mM of KH2PO4, 5mM of KHCO3, 20mM of NaHCO3, 1.57mM of sodium pyruvate, 73.47mM of D,L-sodium lactate, 0.05mM of D-glucose, 0.1mM of Na2EDTAÀ2H2O, 15ml of SNEasS(x66.67), 15ml of SEaaS(x66.67), 0.611mM of L-alanyl-L-glutamine 0.3594mM of glycyl-L-glutamineÀH2O, 1.18mM of L-taurine, 0.003mM of D-Ca-pantothenate, 0.000716mM of choline chloride, 0.00027mM of folic acid, 0.0011mM of i-inositol, 0.000819mM of nicotinamide, 0.000491mM of pyridoxal HCl, 0.0000266mM of riboflavin, 0.000296mM of thiamine HCl, 0.1052mM of penicillin-G, 0.0172mM of streptomycin-S, 0.003mM of phenol red, 42g/L of albumin, 8g/L of globulin 1g/L of hyaluronic acid, 0.000033g/L of insulin, 0.0000333g/L of transferrin, 0.0000000333g/L of sodium selenite, 0.00003g/L of epidermal growth factor, 0.00000278g/L of insulin-like growth factor-II, 0.76U/L, 5.24U/L of FSH, and 1g/L of gelatine.
机译:提供了用于体外胚胎发育的顺序合成培养基组合物,以为在早期胚胎,桑ula和晚期胚胎的每个阶段生长的胚胎提供更多的生理营养,并且当将胚胎移植到胚胎上时能够维持高的妊娠率和着床率。子宫。该组合物由合成培养缓冲液(SCB)和用于早期胚胎生长的合成添加溶液(SAG13)组成,其体积比为85:15。通过溶解91.53mM的NaCl,5mM的KCl,0.8mM的MgSO4-7H2O,1.80mM的CaCl2-2H2O,0.17mM的Na2HPO4、0.08mM的KH2PO4、5mM的KHCO3、20mM的NaHCO3、0.1mM的硫酸钠来制备SCB。 mM D,L-乳酸钠,0.58mM D-葡萄糖,15ml SNEasS(x66.67),15ml SEaaS(x66.67),0.611mM L-丙氨酰-L-谷氨酰胺,0.3594mM甘氨酰-L L-谷氨酰胺-H 2 O,0.003mM D-泛酸钙,0.000716mM氯化胆碱,0.00027mM叶酸,0.0011mM异肌醇,0.000819mM烟酰胺,0.000491mM吡ido醛HCl,0.0000266mM核黄素,0.000296mM 1升超纯水中的盐酸硫胺盐,0.1052mM青霉素-G,0.0172mM链霉素-S和0.003mM酚红。通过溶解14.44mM的NaCl,5mM的KCl,3.5mM的MgSO4-7H2O,1.80mM的CaCl2-2H2O,0.17mM的Na2HPO4、0.08mM的KH2PO4、5mM的KHCO3、20mM的NaHCO3、1.57mM的NaCl来制备SAG13。 mM D,L-乳酸钠,0.05mM D-葡萄糖,0.1mM Na2EDTA‑2H2O,15ml SNEasS(x66.67),15ml SEaaS(x66.67),0.611mM L-丙氨酰-L-谷氨酰胺0.3594 mM糖基-L-谷氨酰胺H2O,1.18mM L-牛磺酸,0.003mM D-Ca-泛酸,0.000716mM胆碱氯化物,0.00027mM叶酸,0.0011mM肌醇,0.000819mM烟酰胺,0.000491mM盐酸吡ido醛,0.0000266mM核黄素,0.000296mM硫胺素,0.1052mM青霉素-G,0.0172mM链霉素-S,0.003mM酚红,白蛋白42g / L,球蛋白8g / L 1g / L透明质酸,胰岛素0.000033g / L,转铁蛋白0.0000333g / L,亚硒酸钠0.0000000333g / L,表皮生长因子0.00003g / L,胰岛素样生长因子II 0.00000278g / L,0.76U / L,5.24U / L的FSH和1g / L的明胶。

著录项

  • 公开/公告号KR100639256B1

    专利类型

  • 公开/公告日2006-10-27

    原文格式PDF

  • 申请/专利权人 MARIA INFERTILITY HOSPITAL;

    申请/专利号KR20050097472

  • 发明设计人 YOON SAN HYUN;LIM JIN HO;KO YONG;

    申请日2005-10-17

  • 分类号C12N5/08;

  • 国家 KR

  • 入库时间 2022-08-21 21:22:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号